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Moyamoya disease  is a unique occlusive disease of the bilateral internal carotid arteries 
with moyamoya vessels. A inherited or acquired disorders and conditions may present in 
conjunction with MMD. This condition is known as quasi-moyamoya disease. We report 
a case of quasi-moyamoya disease complicated with repeated intracerebral hemorrhage 
during long-term follow-up for cerebral ischemia. A 35 year-old woman who had a 
diagnosis of neurofibromatosis type 1 visited our hospital because of incidentally found 
cerebral infarction. Angiography showed occlusive changes in the distal portion of the 
bilateral internal carotid artery and multiple massive collateral arteries from occluded 
internal carotid artery. Since revascularization from external carotid artery systems 
developed, she was treated conservatively and followed annually with radiological study. 
During follow-up, she suffered from minor intracerebral hemorrhages. At age 55, she 
died of massive intracerebral hemorrhages. Although the intracerebral hemorrhage is not 
common in quasi-moyamoya disease, it has a potential to be fatal. Long-term follow-up 
with radiological study and proper surgical treatment are required.  
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Moyamoya disease (MMD) is characterized by the progressive occlusion of the internal 
carotid artery (ICA) or its terminal branches, accompanied by the formation of extensive 
collateral vessels (moyamoya vessels) at the base of the brain. This disease has been 
reported in association with various disease entities including atherosclerosis, 
autoimmune disease, meningitis, brain neoplasm, neurofibromatosis type 1 (NF-1), 
Down syndrome, irradiation to the head [1-3]. These conditions are distinguished from 
MMD according to the diagnostic criteria of the Research Committee on Moyamoya 
Disease (Spontaneous Occlusion of the Circle of Willis) of Ministry of Health and 
Welfare of Japan (RCMJ), and named as quasi-moyamoya disease [4, 5, 6].  
NF-1 is a multisystemic genetic disorder that displays important cutaneous manifestation 
such as café-au-leit spots, freckles and neurofibromas. The incidence of NF-1 is 
approximately one in 2,500 births, affecting all races. The gene for NF-1 is located on the 
long arm of chromosome 17, and more precisely, in the 17q11.2 band. This gene codes for 
neurofibromin, a protein that acts during nervous tissue growth remodeling [7]. The 
susceptibility locus of familial MMD has been mapped to 17q25.3 in Japanese families, 
and the gene was identified as RNF213 [8]. Interestingly, the RNF213 locates near the 
NF-1 gene and occasionally cerebrovascular abnormalities including moyamoya-like 
vasculopathy are accompanied with NF-1.  
The objective of this study is to report on the case of a NF-1 accompanied with 
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quasi-MMD, which manifested cerebral ischemia at first and fatal intracerebral 




At age 10, she was diagnosed with NF-1 on the basis of physical findings 
including café-au-lait spots and multiple subcutaneous neurofibromas (Fig. 1A). She had 
mild mental retardation. At age 35, CT incidentally revealed a low density area in the left 
parietal lobe (Fig. 1B) and she was referred to our department. MRI revealed old 
infarction with atrophy in the left parietal lobe (Fig. 1C). Hemorrhagic change was also 
indentified in the left basal ganglia by the T2* image (Fig. 1D). Hypoperfusion of the 
infarction area was demonstrated by 123I- iodoamphetamine (IMP) single photon 
emission computed tomography (SPECT)  (Fig. 1E). Angiography showed 
steno-occlusive lesion at the terminal portion of the bilateral ICA accompanied with 
massive moyamoya vessels (Fig. 1F, G). Posterior cerebral arteries were also involved 
(Fig. 1H). Collateral flow from external carotid arteries (ECA) were developed (Fig. 1I,J).  
The diagnosis of quasi-MMD associated with NF-1 was made. Since her cerebral 
hypoperfusion was limited in the infraction area, she has been treated conservatively and 
followed with MRI annually. Her physical status and radiological finding were stable for 
17 years. Thus, her habitual blood pressure was 100-120/80-90 mmHg and any 
medication was not required. At age 52, MRI incidentally revealed a new microbleed in 
the right basal ganglia (Fig. 2). At age 53, she was brought to our hospital because of 
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severe headache. Physical examination showed no focal neurological deficit. CT showed 
hemorrhage in the left basal ganglia (Fig. 3A). The hypoperfusion of the left basal ganglia 
was revealed by 123I-IMP SPECT (Fig. 3B). The cerebral blood flow of the right basal 
ganglia was 28.5 ml/100g/min and the left side was 25.8 ml/100g/min. The cerebral 
vascular reserve was 21.3% in the right basal ganglia and 21.7% in the left side. 
Angiography showed regression of the moyamoya vessels especially in the left side (Fig. 
3C-E). During follow-up, the left side lesion was worsened from Suzuki stage 3 to stage 5 
[9]. Apparent cause of the hemorrhage such as aneurysm was not observed. Surgical 
treatment was not performed because of developed collateral flow from ECA as well as 
risk of ischemic complication injuring the collateral vessels. She returned to her usual life. 




We have ever conducted nationwide epidemiological survey on MMD, unilateral MMD, 
and quasi-MMD in 2006 [10]. The annual incidence rate of MMD and quasi-MMD are 
1.13/100,000, and 0.11/100,000 respectively, and the prevalence is 5.22/100,000 and 
0.34/100,000 respectively. It was revealed that the quasi-MMD is a rare disease. It is 
reported that the ratio of quasi-MMD is higher in western country [11]. Regarding with 
clinical manifestation of MMD, it is well known that the pediatric patients present with 
ischemic attack and adult patients tend to suffer from intracranial hemorrhage [12, 13]. 
Main cause of intracranial hemorrhage is rupture of dilated, fragile moyamoya vessels 
 6 
due to hemodynamic stress and hemorrhage occurs in the basal ganglia, thalamus, or 
periventricular lesion. The ratio of intracranial hemorrhage is approximately 20% of 
definite MMD patients and approximately 50% of adult MMD patients [14, 15]. On the 
other hands, data from 109 quasi-MMD patients indicated their imaging study type 
included ischemic type in 64 patients (63.4%), bleeding type in 7 (6.9%), and normal in 
27 (26.7%) [16]. Taken together, intracranaial hemorrhage is relatively less in 
quasi-MMD. Thus, the associated disorders of quasi-MMD were athrosclerosis in 27 
patients (29%), Down syndrome in 14 (15.1%), von Recklinghausen disease in 13 (14%), 
brain tumor/irradiation in 7 (7.5%), autoimmune disease in 7 (7.5%), hyperthyroidism in 
7 (7.5%) [16]. NF-1 is the third major disorder of quasi-MMD.  
In term of NF-1, eight (2.5%) patients among 316 NF-1 patients were found to 
have an abnormality of the cerebrovascular system [17]. Seven patients had a 
vasculopathy diagnosed as an incidental findings on neuroimaging, but a patient 
presented with ischemic stroke. The main characteristic of vascular lesions in patients 
with NF-1 is occlusion of the lumen and hyperplasia of the intima wall. Based on 
microscopic evaluation of the affected vessels, it has been proposed that the vasculopathy 
of NF-1 patients results from abnormal neurofibromin function that leads to excessive 
proliferation of vascular smooth muscle cells during normal maintenance of the vessel 
[18, 19]. In addition to the arterial occlusion, a variety of vascular lesions such as 
aneurysm, pseduoaneurysm, stenosis, fistulae and ruptures have been observed in 
patients with NF-1. Koss et al. report that among 32 cases of quasi-MMD associated with 
NF-1, only one case presented with hemorrhage [20]. Our case suffered from cerebral 
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ischemia at first and repeated minor hemorrhages later. Finally, she died of massive 
intracerebral hemorrhage. It is considered that fragile moyamoya vessels and ischemia or 
hemodynamic change due to the regression of the moyamoya vessels are the cause of the 
hemorrhage. Thus, vacuolar changes of the myelin sheath are found in 60-90% of NF-1 
patients and are typically located in the basal ganglia, thalami, and the cerebral white 
matter [19]. That might affect the hemorrhagic complication in the bilateral basal ganglia 
of our case.  
According to the Japan adult moyamoya trial, extracranial-intracranial bypass 
surgery is effective to reduce incidence of rebleeding and improved patient prognosis [21].  
Surgical revascularization for NF-1 appears safe and is protective against further 
ischemic and neurological damage [20]. Vascular reconstruction was discussed in this 
case. However, collateral flow from ECA had been developed. Bypass surgery for the 
case with well developed collateral circulation is challenging and the effective blood 
supply to the basal ganglia has not been established. That is why, she was treated 
conservatively. Close monitoring of these abnormalities is warranted because the 
long-term outcome of these vascular lesion is unknown. Early recognition of a disease 




We reported a case of NF-1 complicated with cerebral ischemia and repeated 
intracerebral bleeding due to the progression of quasi-MMD. A long-term follow-up is 
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required to detect progression of cerebrovascular disease.  
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Fig. 1 Patient at 35 years old.  
A: A photograph of upper extremities shows multiple subcutaneous neurofibromas.  
B: CT shows low density area in the left parietal lobe.  
C: MRI fluid attenuated inversion recovery image shows old infarction with atrophy in 
the left parietal lobe.  
D: MRI T2* image reveals hypointensity lesion, indicating microbleed in the left basal 
ganglia (arrow).  
E: Hypoperfusion of the infarction area is demonstrated by 123I- iodoamphetamine (IMP) 
single photon emission computed tomography (SPECT).  
F, G: Right (F) and left (G) carotid angiography shows steno-occlusive lesion at the 
terminal portion of the bilateral internal carotid artery accompanied with massive 
moyamoya vessels.  
H: Right vertebral angiography shows involvement of the posterior cerebral arteries.  
I, J: Right (I) and left (J) external carotid angiography shows collateral flow from middle 
meningeal artery (arrow) and superficial temporal artery (arrow head) was developed.  
 
Fig. 2 Patient at 52 years old.  
MRI T2* image reveals microbleed in the right basal ganglia (arrow).  
 
Fig. 3 Patient at 53 years old.  
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A: CT reveals minor hemorrhage in the left basal ganglia.  
B: 123I-IMP SPECT shows hypoperfusion in the left basal ganglia (arrow).  
C: Right carotid angiography shows steno-occlusive lesion at the terminal portion with 
moyamoya vessels.  
D: Left carotid angiography shows steno-occlusive lesion at the terminal portion with a 
regression of moyamoya vessels.  
E: Left vertebral angiography shows involvement of the posterior cerebral arteries with 
regression of moyamoya vessels.  
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